| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/29/2004 | WO2003004606A3 Antisense oligonucleotides and related methods for regulating cell death |
| 01/29/2004 | WO2003002137A3 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis |
| 01/29/2004 | WO2003000199A3 Ilt3 and ilt4-related compositions and methods |
| 01/29/2004 | WO2002099060A3 Dgks as modifiers of the p53 pathway and methods of use |
| 01/29/2004 | WO2002095001A3 Btf3: an inhibitor of apoptosis |
| 01/29/2004 | WO2002090503A3 Anti-microbial peptides and compositions |
| 01/29/2004 | WO2002086134B1 Buffer solution for electroporation and a method comprising the use of the same |
| 01/29/2004 | WO2002083900A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/29/2004 | WO2002072794A3 Immunoglobulin superfamily proteins |
| 01/29/2004 | WO2002068652A3 Nov-x proteins and nucleic acids encoding same |
| 01/29/2004 | WO2002064014A9 Endomural therapy |
| 01/29/2004 | WO2002038106A3 Calcilytic compounds |
| 01/29/2004 | US20040019929 Aromatic amino acid biosynthetic enzymes |
| 01/29/2004 | US20040019919 Calsyntenin-1-3 proteins, predominantly expressed in the nervous system , useful for the screening and for the preparation of a medicament for the treatment of nervous system disorders, most preferably brain |
| 01/29/2004 | US20040019917 NEOKINE protein and nucleic acid molecules and uses therefor |
| 01/29/2004 | US20040019916 In vivo homologous sequence targeting in eukaryotic cells |
| 01/29/2004 | US20040019361 Method, instruments, and kit for autologous transplantation |
| 01/29/2004 | US20040019194 Ixodes salivary anticomplement protein |
| 01/29/2004 | US20040019190 Thrombopoietin mimetics |
| 01/29/2004 | US20040019189 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen |
| 01/29/2004 | US20040019186 Complex of lecithin and sugar; immobilization; washing; liquid removal; recovering |
| 01/29/2004 | US20040019185 Process for preparing purified active monomer of bone-derived factor |
| 01/29/2004 | US20040019184 Remedies for ischemic disease |
| 01/29/2004 | US20040019182 Reagents and methods for assaying Bacillus anthracis lethal factor protease |
| 01/29/2004 | US20040019181 Antimicrobial cationic peptides |
| 01/29/2004 | US20040019102 Administering a thiuram disulfide and a heavy metal ion; activated transcription factor/adenosine cyclic phosphate response element binding protein (atf/creb) |
| 01/29/2004 | US20040019083 Amino acid derivatives; antineoplastic agents |
| 01/29/2004 | US20040019074 Mixtures of fatty esters, lipophilic excipients and nonionic surfactants, used as solubilizers for drugs selected from rapamycin, tacrolimus, deoxyspergualin, mycophenolate-mofetil, nifedipine, nimodipine, etoposide or ibuprofen |
| 01/29/2004 | US20040019072 Dimer-selective RXR modulators and methods for their use |
| 01/29/2004 | US20040019066 Methionine salvage pathway in bacillus |
| 01/29/2004 | US20040019036 Treating a related myeloproliferative disorder or a Ph-positive acute lymphocytic leukemia; able to induce or to improve hematologic response and/or cytogenetic response and, eventually, survival, with a mild non-hematologic toxicity |
| 01/29/2004 | US20040019011 Treatment of conitions and disease |
| 01/29/2004 | US20040019009 A compound 8 to 50 nucleobases in length targeted to a nucleic acid molecule, specifically hybridizes with such nucleic acid, encoding IL-1 receptor-associated kinase-4; useful for treating cancer, infection and inflammation |
| 01/29/2004 | US20040019006 Diagnosis, analyzing neuropathic pain; genetic engineered polypeptides |
| 01/29/2004 | US20040019004 Anticancer agents; antitumor agents |
| 01/29/2004 | US20040019003 Nek2 inhibitors |
| 01/29/2004 | US20040019001 Modulation gene expression |
| 01/29/2004 | US20040018999 Methods and compositions for RNA interference |
| 01/29/2004 | US20040018992 Pharmaceutical compositions for sparingly soluble therapeutic agents |
| 01/29/2004 | US20040018986 Viricide against hepatitis virus |
| 01/29/2004 | US20040018985 Enhanced hematopoiesis |
| 01/29/2004 | US20040018984 Methods for preventing adhesion formation using protease inhibitors |
| 01/29/2004 | US20040018981 Glucagon-like peptide-1 (glp-1) receptor agonist |
| 01/29/2004 | US20040018980 Novel FIZZ proteins |
| 01/29/2004 | US20040018979 Anticholesterol agents |
| 01/29/2004 | US20040018978 Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain |
| 01/29/2004 | US20040018977 Semaphorin-like proteins and methods of using same |
| 01/29/2004 | US20040018976 Polypeptide for diagnosis, therapy |
| 01/29/2004 | US20040018975 Glucagon-like peptides; reducing body weight |
| 01/29/2004 | US20040018972 Autoimmune diseases; antiallergens; rheumatic diseases; antiinflammatory agents |
| 01/29/2004 | US20040018971 Anticancer agents; vaccine |
| 01/29/2004 | US20040018970 Novel nucleic acids and polypeptides and methods of use thereof |
| 01/29/2004 | US20040018969 Genetic engineering; central nervous system disorders |
| 01/29/2004 | US20040018968 Use of histone deacetylase inhibitors in combination with radiation for the treatment of cancer |
| 01/29/2004 | US20040018967 Ligand/lytic peptide compositions and methods of use |
| 01/29/2004 | US20040018965 Adult-onset diabetes treatment method |
| 01/29/2004 | US20040018961 Forming micelles in aqueous solution; adjustment pH; stabilization |
| 01/29/2004 | US20040018959 System and methods of lipid removal from the body |
| 01/29/2004 | US20040018958 Methods for therapy of radiation cutaneous syndrome |
| 01/29/2004 | US20040018957 Screening ligands which modulation interaction; antiproliferative agents |
| 01/29/2004 | US20040018639 Using extract from mammal thymus glands; analyzing precipitation patterns |
| 01/29/2004 | US20040018619 Central nervous system disorders; psychological disorders; therapy for brain tumors |
| 01/29/2004 | US20040018618 Genetic engineering; hybrid proteins; gene expression; human gene therapy |
| 01/29/2004 | US20040018605 Anticancer agents; autoimmune diseases; central nervous system disorders; polymerase chain reactions |
| 01/29/2004 | US20040018595 Production of recombinant bmp-2 |
| 01/29/2004 | US20040018594 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 01/29/2004 | US20040018571 PSCA: prostate stem cell antigen and uses thereof |
| 01/29/2004 | US20040018558 Method for identifying modulators of G protein coupled receptor signaling |
| 01/29/2004 | US20040018555 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 01/29/2004 | US20040018547 Ion channel receptor and uses thereof |
| 01/29/2004 | US20040018545 Nucleic acids; genetic engineering; culture product |
| 01/29/2004 | US20040018542 Phosphodiesterase enzymes |
| 01/29/2004 | US20040018540 Evaluation method of interferon beta treatment against multiple sclerosis |
| 01/29/2004 | US20040018516 Ixodes scapularis tissue factor pathway inhibitor |
| 01/29/2004 | US20040018514 Nucleotide sequence derived from Listeria inocua |
| 01/29/2004 | US20040018508 Surrogate antibodies and methods of preparation and use thereof |
| 01/29/2004 | US20040018487 Methods of diagnosing cervical cancer |
| 01/29/2004 | US20040018243 Modulation of release from dry powder formulations |
| 01/29/2004 | US20040018240 Method for producing preparation containing bioactive substance |
| 01/29/2004 | US20040018237 Topical drug delivery using phosphatidylcholine |
| 01/29/2004 | US20040018229 Insoluble drug delivery |
| 01/29/2004 | US20040018214 Treating a non-spasm caused pain with botulinum toxin |
| 01/29/2004 | US20040018213 Treating a non-spasm caused pain with botulinum toxin |
| 01/29/2004 | US20040018212 Treating a non-spasm caused pain with botulinum toxin |
| 01/29/2004 | US20040018206 Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens |
| 01/29/2004 | US20040018205 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof |
| 01/29/2004 | US20040018204 Compositions and methods for WT1 specific immunotherapy |
| 01/29/2004 | US20040018198 Antibodies against carbonic anydrase IX (CA IX) tumor antigen |
| 01/29/2004 | US20040018196 Proteins and nucleic acids encoding same |
| 01/29/2004 | US20040018190 Drugs and foods improving the quality of life and process for producing the same |
| 01/29/2004 | US20040018188 Sparc-related proteins |
| 01/29/2004 | US20040018187 Attenuation of fibroblast proliferation |
| 01/29/2004 | US20040018186 Administering chondroitinases expressed from genetic engineered nucleotide sequences in bacteria, as angiogenesis inhibitors, antitumor or anticarcinogenic agents |
| 01/29/2004 | US20040018185 Human kinases |
| 01/29/2004 | US20040018184 Administering mixtures of monocytes and drugs selected from taxanes, alkaloids, antibiotics or enzyme inhibitors, as anticarcinogenic agents |
| 01/29/2004 | US20040018181 MUC1 interference RNA compositions and methods derived therefrom |
| 01/29/2004 | US20040018180 Administering hematopoietic stem cells for activation of glands, to improve immune response to vaccines; leutinizing hormone-releasing hormone |
| 01/29/2004 | US20040018179 Bioadhesive directed somatic cell therapy |
| 01/29/2004 | US20040018176 Compositions and methods for siRNA inhibition of angiogenesis |
| 01/29/2004 | US20040018173 Composition and method for the treatment and prevention of metastatic disorders |